Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no approved half-dose setting on any Mounjaro KwikPen. Each pen is pre-set to deliver one fixed, complete dose per injection — the click you hear is a mechanical indicator, not a volume selector. Splitting a dose by counting clicks is not a recognised or licensed method of administering tirzepatide, and clinical guidance does not support it. If your current dose feels too strong, that is a conversation for your prescribing clinician, not a problem to solve with pen mechanics. Mounjaro is a prescription-only treatment that must be used exactly as a registered prescriber directs.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When you prepare a Mounjaro KwikPen, you are not adjusting a dial or drawing up a quantity from a vial. The pen is factory-loaded with a fixed amount of tirzepatide solution and engineered to expel the entire contents of that single dose in one continuous injection. Pressing the button starts a spring-driven mechanism. The click (sometimes more than one sound) is the device confirming the plunger is moving and that medicine is being delivered. There is no logical stopping point mid-injection that corresponds to a meaningful fraction of the dose.
Some people assume that because they can hear distinct sounds, each click must represent a measurable unit. It does not. The audible feedback is a design feature for confidence and accessibility, particularly for people injecting into a site they cannot see clearly. Stopping the injection early does not reliably deliver half the medicine, it is more likely to waste medicine in the needle or deliver an unpredictable, unverified quantity. The NHS medicines page for tirzepatide is clear that the pen should be used as directed in the Patient Information Leaflet.
For anyone curious about dose-specific questions (for instance, questions that come up around the 5mg pen) the detail on what the 5mg pen contains and how it works covers the practical points without straying into unofficial guidance.
The impulse to take less than a full dose usually comes from one place: side effects that feel hard to manage, most often nausea, tiredness, or digestive discomfort in the first days after an injection or a dose step. That discomfort is real and common. The licensed schedule is built around it.
The 2.5mg dose exists precisely because it is the minimum amount the clinical programme found to be tolerable for most people. It is not a therapeutic dose in the sense of producing meaningful weight loss by itself, its job is to let your body adjust before you move up. Spending at least four weeks there before any increase is the standard approach, guided by your prescriber. The SURMOUNT-1 trial, which assessed tirzepatide across doses up to 15mg in thousands of adults with obesity and reported findings in the New England Journal of Medicine, used this titration structure throughout, precisely because slow escalation is what keeps patients on treatment.
If you are already on 2.5mg and finding it hard, the answer is not a fractional dose below the licensed floor. A prescriber can review the pace of titration, consider whether underlying factors are making side effects worse, and advise on practical steps, eating before your injection, staying well hydrated, keeping the pen at the right temperature. Speaking of storage: many people keep their current pen in the fridge door next to everyday items, which is fine, but always check the Patient Information Leaflet for the exact temperature and room-temperature window, the numbers matter and do change with different presentations.
Questions about click counts for half doses circulate widely online, usually on forums where people are trying to stretch a pen or manage costs. Both motivations are understandable. But acting on them carries real risk: an unverified dose of a prescription medicine is not the same as a clinically adjusted one, and the pen is not designed for partial delivery. If you want to understand what the click sounds on a Mounjaro pen actually mean and why they do not map to half a dose, that detail is worth reading before drawing any conclusions.
If cost is part of the picture, it is worth knowing that a structured private consultation with a registered prescriber costs nothing at nume, and a prescriber who understands your full history is far better placed to help than a click-count workaround. If tolerability is the issue, your prescriber may be able to adjust the titration pace or look at what is driving the side effects. If you have questions about the range of dose steps across the Mounjaro schedule, the overview of how Mounjaro works and what the dose steps look like covers this in context.
For people exploring partial-dose questions because they are considering a different pen strength (for example, those wondering about how click counts relate to half a dose on the 5mg Mounjaro pen specifically) the page on half-dose mechanics across the Mounjaro pen range addresses those specifics. And anyone thinking about starting treatment or moving between doses will find our frequently asked questions a useful first stop before speaking to a clinician.
Mounjaro is a Black Triangle medicine (▼), meaning it is subject to additional MHRA monitoring. Patients can report any suspected side effect through the MHRA Yellow Card scheme, which also accepts reports about suspect products or sellers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.